CI Cigna
Data as of close
Financial · Hospital & Medical Service Plans
Cigna (CI) is a financial company in the Hospital & Medical Service Plans industry, with a market capitalization of $78.0 billion. Shares last traded at $295.19, 6.6% below their 52-week high. Over the past year the stock is up 19.5%. CI trades at a price-to-earnings ratio of 13.09, below the Hospital & Medical Service Plans median of 24.01. Net profit margin is 2.1%, above the peer median of 1.1%. Revenue grew 11.2% year over year. The shares yield 2.1% in dividends.
* P/E (TTM) = market cap ÷ net income over the trailing twelve months where four consecutive quarters are reported, otherwise the latest fiscal year — the same basis as the peer table and the screener, so it can differ from price ÷ EPS.
Performance
Chart
Full chart →Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.
Technicals
Financials
Trailing twelve months where four consecutive quarters are reported, otherwise the latest fiscal year; revenue is the fiscal-year figure where quarterly revenue covers under half of it (typical for banks, insurers and REITs), and margins are taken on it; latest reported period ends 2026-06-30. Source: SEC EDGAR/XBRL.
CI Dividend History
| Fiscal year end | Total dividends paid | Per share* | Payout ratio |
|---|---|---|---|
| 2025-12-31 | $1.61B | $6.00 | 27% |
| 2024-12-31 | $1.57B | $5.53 | 46% |
| 2023-12-31 | $1.45B | $4.88 | 28% |
| 2022-12-31 | $1.38B | $4.42 | — |
| 2021-12-31 | $1.34B | $3.93 | — |
| 2020-12-31 | $15M | $0.04 | — |
| 2019-12-31 | $15M | $0.04 | — |
*Per share derived as total dividends paid ÷ weighted diluted shares (SEC EDGAR/XBRL annual cash-flow facts). Reported history — not a forecast of future dividends.
Compare payers on the highest-dividend-yield screener.
Recent earnings
| Period | EPS (diluted) | Reported |
|---|---|---|
| Q2 2026 | $6.29 | 2026-07-30 |
| Q1 2026 | $6.26 | 2026-04-30 |
| Q4 2025 (derived) | $4.64 | 2026-02-26 |
| FY 2025 | $22.18 | 2026-02-26 |
| Q3 2025 | $6.98 | 2025-10-30 |
| Q2 2025 | $5.71 | 2025-07-31 |
Q4 marked "derived" = fiscal-year EPS minus Q1–Q3 (10-Ks report only the annual figure); EPS is not strictly additive, so it can differ by a cent or two from the issuer's own Q4.
Hospital & Medical Service Plans peers
CI vs 10 industry peers (Hospital & Medical Service Plans), by market cap. Data as of close
| UNH | UnitedHealth Group | $359.4B | 25.45 | 0.80 | 3.1% | -1.54% |
| ELV | Elevance Health | $89.4B | 17.39 | 0.44 | 2.5% | -1.47% |
| CI | Cigna | $78.0B | 13.09 | 0.28 | 2.1% | -1.03% |
| HUM | Humana | $49.3B | 43.59 | 0.36 | 0.8% | -0.97% |
| CNC | Centene Corporation | $32.9B | 22.56 | 0.18 | 0.8% | -2.80% |
| MOH | Molina Healthcare, Inc. | $10.9B | — | 0.25 | -0.1% | +1.88% |
| OSCR | Oscar Health, Inc. | $9.6B | 17.37 | 0.82 | 4.7% | +2.11% |
| CLOV | Clover Health Investments, Corp. /De | $2.3B | — | 0.93 | -3.5% | -3.25% |
| ALHC | Alignment Healthcare, Inc. | $1.5B | 50.48 | 0.30 | 0.6% | -4.32% |
| TRUP | Trupanion, Inc. | $1.4B | 69.49 | 0.89 | 1.3% | +1.99% |
Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.